Evaluate the Effects of Famotidine or Rabeprazole on the PK of Nirogacestat
Clinical trial NCT07171619 · COMPLETED
Trial details
- NCT number
- NCT07171619
- Sponsor
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-21
- Primary completion
- 2025-11-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.